consists of two polypeptides, TAP1 and TAP2. TAP delivers peptides † Babraham Technix, The Babraham Institute, into the ER and forms a "loading complex" with MHC class I molecules and Babraham, Cambridge CB2AT, United accessory proteins. Our previous experiments indicated that nucleotide Kingdom. binding to TAP plays a critical role in the uptake of peptide and the release of assembled class I molecules. To investigate whether the conserved hydrolysis at one TAP chain induces ATP binding at the other chain; this leads to an alternating and interdependent catalysis of both NBDs. Furthermore, our data suggest that the peptide-mediated undocking of MHC class I is linked to the transport cycle of TAP by conformational signals arising predominantly from TAP1.
Background
tide binding have been reported for several ABC transporters [10] [11] [12] [13] . Major histocompatibility complex (MHC) class I molecules bind antigenic peptides in the ER and transport
Mutations that prevent nucleotide binding to the NBDs them to the cell surface for recognition by cytotoxic T of TAP inhibit the peptide binding capacity of the transcells. Most of these peptides are generated in the cytosol porter, and this finding argues for a tight functional couand are translocated into the ER by the transporter associpling of the NBDs and the peptide binding site [9] . Moreated with antigen processing (TAP). TAP is composed of over, nucleotide and peptide binding to the transporter two polypeptide chains, TAP1 and TAP2, [1, 2] and is a seems to affect the overall conformation of the transporter member of the ATP binding cassette (ABC) transporter [14] . Previously, we investigated the effect of nucleotide family [3] . TAP forms a loading complex with MHC class binding on TAP function by generating "symmetrical" I molecules through a bridging protein, tapasin, and two mutant TAP molecules in which both NBDs were defecchaperones, calreticulin and ERp57 [4] [5] [6] .
tive in nucleotide binding [9] . Our results suggested that the binding and transport of peptide by TAP are kinetLike other ABC transporters, TAP has two transmemically coordinated with the binding of peptide to the MHC brane and two highly conserved nucleotide binding doclass I molecule and the subsequent release of the MHC mains (NBDs). The substrate transport of ABC transporters class I molecule from the loading complex. is strictly ATP dependent [7] [8] [9] . Binding and hydrolysis of nucleotides is thought to drive the transport process by Here, by introducing mutations into the NBDs of either TAP1 or TAP2, we asked whether the two conserved transducing conformational changes from the NBDs to the transmembrane domains [10] . In support of this view, NBDs are equally involved in the peptide transport process. We found that the binding and transport of peptides substantial conformational changes resulting from nucleo- by TAP depend on the ability of both NBDs to bind nucleotides but that TAP1 and TAP2 are functionally distinct. The nucleotide binding preferences of the two chains are different, and homologous mutations in the NBDs of the two TAP chains, neither of which affects nucleotide binding, have radically different effects on peptide transport. Furthermore, the undocking of assembled MHC class I depends on conformational signals arising predominantly from TAP1. We present a working model in which nucleotide binding by TAP coordinates the uptake and subsequent peptide transport with the binding, loading, and release of MHC class I molecules from the TAP complex.
Results

Distinct nucleotide binding properties of TAP1 and TAP2
We showed earlier that symmetrical mutations of the conserved glycines at position 1 and 6 of the Walker A motif (GXXGXGKS/T, in the single-letter amino acid code) of both TAP chains to valine or serine, both of which blocked nucleotide binding, did not interfere with the formation of the class I loading complex on TAP but blocked peptide transport and, surprisingly, peptide binding of TAP [9] . Based on these studies, we asked whether the NBDs of the two TAP chains are functionally equivalent by expressing in the TAP-deficient human cell line T2 asymmetrical combinations of rat wild-type TAP1 together with mutant TAP2 or vice versa. Glycine-to-valine and glycine-to-serine mutations in the Walker A motif were termed, respectively, mutations I and II [9] . T2 transfectants were termed as follows: T2-1/2 I (mutation I in TAP2), T2-2/1 I (mutation I in TAP1), T2-1/2 II (mutation II in TAP2), and T2-2/1 II (mutation II in TAP1).
Western blot analysis confirmed the expression of both TAP chains at comparable levels in all transfectants. Fur- with this article on the internet).
Control lysates correspond to 2 ϫ 10 5 cells. After washing the nucleotide-agarose, we eluted bound proteins with SDS sample buffer and analyzed them in Western blots probed for rat TAP1 and
To compare the nucleotide binding capacities of wild-TAP2. It should be noted that only isolated membrane fractions type TAP with the different asymmetrical TAP mutants, could be used for these kind of experiments since total cell lysates gave nonspecific TAP binding to nucleotide-agaroses (O. D. and we performed nucleotide binding assays [9] . The binding [9], wild-type TAP bound to ADP-and ATP-but not to for 1 min. In a control sample, the interaction of TAP with 8-azido-ATP[␥- AMP-agarose ( Figure 1a ). All the asymmetric TAP variAfter UV crosslinking, membranes were lysed in Triton X-100, and ants bound ADP-but not AMP-agarose. However, they TAP was immunoprecipitated with anti-rat TAP2 antiserum (right panel) differed markedly in their ability to bind ATP-agarose.
and separated on a 7.5% SDS gel. For identification of the TAP1 and TAP2 chains, lysates of T2-TAPwt, T2-TAP1 (expressing only TAP1), and T2-TAP2 (expressing only TAP2) were analyzed by a Western blot probed for rat TAP2 and TAP1 (left panel Those variants carrying mutations in the NBD of the TAP2 chain (1/2 I and 1/2 II) bound ATP-agarose as well as the wild type did. In contrast, transporters carrying mutations in the TAP1 chain (2/1 I and 2/1 II) did not bind ATP-agarose at all, despite having bound ADP-agarose well. We therefore suggest that only TAP1 has a high-affinity ATP binding site in the resting molecule. In order to test this notion, we investigated nucleotide binding by TAP1 and TAP2 in wild-type TAP by using photolabeling with free 8-azido-ATP[␥-32 P]. Isolated membranes of T2-TAPwt were incubated with 8-azido-ATP[␥-32 P], protein bound nucleotides were crosslinked by UV irradiation, and TAP was immunoisolated from lysates. The labeling efficiency for TAP1 was markedly higher than for TAP2 (Figure 1b) . Phosphorimager quantitation revealed that 90% of the activity is located in TAP1 and only 10% in TAP2. The distribution of labeling should represent the ATP binding capacities of TAP chains in a functional heterodimer because TAP1 chains were coisolated in anti-TAP2 immunoprecipitates. We wondered whether the distinct nucleotide binding behaviors of the two chains in the heterodimeric complex re- we observed nearly no binding to ATP-agarose. Single was detected by flow cytometry (filled histograms). We determined background staining by incubating with secondary antibody only TAP chains appeared to bind to nucleotide-agaroses less (nonfilled histograms).
efficiently than did the wild-type transporter relative to lysate controls. Nevertheless, the properties of the individual TAP chains from single-chain transfectants reflected the properties of the chains inferred from their results show that the integrity of both NBDs is required behavior in TAP heterodimers. In summary, these data for the transport activity of TAP, as has been shown for suggest that the observed ATP binding of resting TAP other ABC transporters [15] . is mediated predominantly by TAP1, while both subunits of TAP contribute to the observed ADP binding activity.
Peptide uptake by TAP depends on nucleotide binding [9] . To analyze whether the NBDs of both TAP chains
Binding and transport of peptides by TAP depend contribute to the nucleotide dependency of peptide bindon functionality of both NBDs ing, we incubated permeabilized cells of the various T2 Recent data provided evidence that peptide binding and cell lines with photoreactive, radioiodinated peptide S8. transport by TAP are abrogated when both NBDs are After UV crosslinking, immunoisolated TAP was sepadefective in nucleotide binding [9] . To assess the individrated by SDS-PAGE. Crosslinking of radiolabeled pepual contributions of the two chains to these activities, we tide S8 to TAP was detectable for the wild-type transperformed a standard transport assay with the asymmetriporter but negligible for all of the mutant transporters cal TAP mutants by using iodinated model peptide S8
( Figure 3 ). Thus, nucleotide binding in both TAP chains (TVDNKTRYR, in the single-letter amino acid code) [9] .
is required for the uptake of peptide by the transporter. In contrast to wild-type TAP, no peptide transport above background could be detected for any mutant TAP ( confirmed when the surface expression of HLA-B5 was
We previously showed that peptide-induced dissociation analyzed by FACS (Figure 2b ). T2 cells expressing muof the TAP-MHC class I complex is blocked in symmetritant TAP variants had levels of HLA-B5 surface exprescal TAP NBD mutants [9] . It was therefore of interest to see whether the implied conformational effects of nucleosion no greater than that of untransfected T2 cells. These It has been suggested that nucleotide dissociation from TAP reduces its thermal stability [14] and that irreversible changes in TAP conformation induced by incubation at 37ЊC can be prevented by nucleotide binding to TAP1. It was possible that such conformational injury to nucleotide-free transporters might have contributed to the block of peptide-dependent class I release in symmetrical [9] and asymmetrical TAP NBD mutants. We therefore investigated peptide-dependent class I MHC dissociation from TAP in solubilized T2-TAPwt cells which had been depleted of ATP in vivo by incubation with antimycin A and 2-deoxyglucose [16] . Treatment with both metabolic inhibitors caused a drastic decrease in the cellular ATP level of T2-TAPwt cells. After 45 min incubation at 37ЊC, the cellular ATP pool was almost completely depleted (data not shown). Cells, treated with antimycin A and nucleotide-depleted lysates ( Figure 4b ). Most notably, the addition of 3 mM MgATP eliminated this effect. MgATP without peptide gave only a slight reduction in tide binding on breakdown of the loading complex could the signal of coisolated class I molecules; this reduction be specifically attributed to one chain of TAP. Digitoninwas perhaps caused by a small population of complexes solubilized cells of T2 transfectants carrying the various in the cells in which TAP-bound class I molecules are asymmetrical TAP NBD mutants were incubated with a already loaded with peptides [17] . In summary, the block 1:1 mixture of HLA-A2 and HLA-B5 binding peptides in class I release from TAP in the absence of nucleotides is at 37ЊC for 60 min [9] . After immunoisolation of TAP not secondary to an irreversible, temperature-dependent complexes with anti-TAP2 antiserum, coisolation of MHC structural change in the conformation of nucleotide-free class I was analyzed by Western blotting with a monotransporters. clonal antibody against HLA-A and -B molecules ( Figure  4a ). MHC class I molecules that were associated with TAP1 and TAP2 serve different functions wild-type TAP were released nearly completely by incuduring peptide transport bation with peptides (approximately 90% reduction of the Asymmetrical TAP NBD variants deficient in nucleotide class I signal). Complexes of MHC class I and mutant binding reveal distinct properties of TAP1 and TAP2 in TAPs carrying wild-type TAP1 (TAP1/2 I and TAP1/2 both nucleotide binding and peptide-mediated class I II) showed peptide-mediated dissociation comparable to release; this finding suggests that the subunits fulfil disthat of the wild-type complex. However, asymmetrical tinct functions during the transport cycle. We next wanted TAP mutants with mutant TAP1 (TAP2/1 I or TAP2/1 to examine mutations in the Walker A motif of TAP1 and II) showed only a partial release of class I molecules by TAP2 that should not affect nucleotide binding but that peptides. Quantification of the class I signals by microdenmight interfere with the catalytic activity of the NBDs. sitometry obtained for TAP2/1 I or 2/1 II revealed that
Residues at position 2 and 3 of the Walker A motif display only 30%-50% of associated MHC class I molecules are considerable sequence variation within different GTPases released from the TAP complex upon incubation with and ATPases [18] and seem to have functional imporpeptides. Since TAP2/1 I and 2/1 II show persistent affintance, as has been shown for nucleotide binding proteins ity for ADP (Figure 1a) , we asked whether the partial such as adenylate kinase and p21 ras [19, 20] . It has been inhibition of the dissociation process could be due to speculated that sequence variations in the Walker A motif limiting concentrations of ADP in the cell lysates. Howreflect adaptation to distinct catalytic functions of differever, the external addition of even 1 mM ADP or ATP ent nucleotide binding proteins [18] . Therefore, we redid not boost peptide-mediated class I release for either placed the residues proline and asparagine in the Walker TAP2/1 I or TAP2/1 II (data not shown). Thus, the nucleo-A site at positions 2 and 3 with serine, which can be found tide dependency of peptide-mediated TAP/MHC I dissoin the same positions in other prokaryotic and eukaryotic ciation seems to be mainly controlled by the nucleotide binding state of TAP1.
ABC transporters [3, 15] . This TAP mutation is referred to as MUT III. TAP varipressing MUT III in both chains showed a transport activity reduced by 50% relative to wild-type TAP, while the ants carrying MUT III in either TAP1, TAP2, or both chains were transfected stably into T2 cells. The resulting two asymmetrical MUT III mutants differed radically from each other. When the MUT III mutation was only asymmetrical transfectants, which we have designated T2-1/2 III (MUT III in TAP2) and T2-2/1 III (MUT in the TAP1 chain (TAP2/1 III), the transport activity of TAP was, if anything, even more efficient than that of III in TAP1), and the symmetrical mutant T2-MUT III (both TAP chains mutated) were tested for TAP expresthe wild type, while the transport activity of TAP1/2 III was drastically decreased (approximately 10% of the wildsion by Western blot analysis. All cell lines expressed both TAP chains in amounts comparable to that of T2-type transporter). The different peptide transport activities were also reflected in different HLA-B5 surface exTAPwt and formed loading complexes ( Figure S2 ). Nucleotide binding of the different TAP variants was anapression levels determined by FACS analysis (Figure 6b ). However, neither T2-Mut III nor T2-1/2 III showed a lyzed as described above (Figure 1 ) and showed that introduction of the eukaryotic consensus sequence into the defect in peptide binding ( Figure S3 ). Walker A motif had no effect on the nucleotide binding In summary, MUT III has strikingly different effects on capacity of the transporter ( Figure 5 ). Both asymmetrical peptide transport activity depending on whether it is presand symmetrical MUT III TAP NBD mutants showed ent in the Walker A sequence of TAP1 or of TAP2, and wild-type levels of binding to ADP-and ATP-agarose.
these results strongly suggest that the TAP chains serve Furthermore, single expressed TAP1 and TAP2 chains different functions during the transport process. Furthercarrying MUT III have the same nucleotide binding prefmore, the fact that the presence of MUT III in both TAP erences as do the corresponding wild-type TAP chains chains leads to transport activity intermediate between (data not shown and Figure 1c) . that of TAP1/2 III and TAP2/1 III supports the view of an interdependent action of both TAP chains during the The MUT III mutation had striking effects on peptide transport (Figure 6a ). The symmetrical TAP variant extransport cycle. binding for the single chains is much lower than for the TAP heterodimers, which indicates that subunit assembly favors correct domain folding. Nevertheless, the differential nucleotide binding properties of TAP1 and TAP2 are determined at least in part by intrinsic properties of the TAP chains. These results suggest that, under experimental conditions not allowing nucleotide hydrolysis, ATP binding to TAP is mediated by TAP1, while TAP2 is barely accessible for ATP. A possible explanation of this phenotype could be that ATP is tightly bound by the NBD of TAP2; therefore, ATP binding to TAP 2 could not be detected with the methods applied here. Still, ADP binding to TAP2 was clearly detectable, which indicates that the NBD of TAP2 is accessible for nucleotides and speaks in favor of a specific mechanism to prevent ATP binding to TAP 2 in the ground state of the transporter. Russ et al. [21] also found pronounced labeling of human TAP1 with 8-azido-ATP but attributed it to differences in the expression level of TAP1 and TAP2 in their experimental system and concluded that TAP1 and TAP2 may well have similar affinities for ATP. Our findings on rat TAP suggest that the nucleotide binding behavior of human TAP should be reinvestigated.
Studies on P-glycoprotein report differences in ATP binding to the N-and C-terminal NBD. Specific chemical modification of the N-terminal NBD strongly inhibited ATP binding, while modification of the C-terminal NBD had no effect on ATP binding [22] . Hrycyna et al. [23] showed under conditions that prevent ATP hydrolysis that P-glycoprotein binds ATP predominantly with the N-terminal NBD. However, under conditions that allow hydrolysis, the C-terminal NBD was preferentially la- . Since we found preequivalent or distinct roles during the transport cycle. We dominant labeling for ATP of the TAP1 chain, it is tempthave used TAP variants in which only one of two TAP ing to speculate that it is TAP 1 that initiates the transport chains carried mutations in the ATP binding site to show cycle of TAP after peptide binding. Upon hydrolysis of that TAP1 and TAP2 have distinct biochemical and functional properties in the transporter.
ATP at TAP 1, the NBD of TAP 2 would become accessible for ATP. ATP binding and hydrolysis at TAP 2 might in turn be necessary to complete the transport cycle. The nucleotide binding capacities of TAP1 and TAP2 are different. ATP bound almost exclusively to TAP1 in
In our previous study, we observed that mutational damthe TAP heterodimer (Figure 1b) , and TAP1 molecules age to the two nucleotide binding sites also prevented from single-chain transfectants bound both ATP and peptide binding by TAP [9] . Here we show that both ADP, while TAP2 from single-chain transfectants bound only ADP (Figure 1c) . The overall efficiency of nucleotide NBDs have to be functional for peptide uptake ( Figure Figure 6 3). Thus, in TAP as in other ABC transporters, nucleotides perform as allosteric regulators by mediating different conformational states in the substrate binding site, a function distinct from their role in using the energy of ATP hydrolysis to drive peptide transport. This allosteric regulation also affects the interaction of TAP with MHC class I molecules. Li et al. [17] demonstrated that peptideloaded MHC class I molecules are released from the loading complex by incubation with ATP. We found that the peptide-mediated dissociation of MHC class I molecules from the loading complex was blocked when both NBDs were functionally disrupted [9] . Now we show that this block arises mainly from TAP1 ( Figure 5 ). TAP-associated class I MHC molecules are bound preferentially (presumably with tapasin) through TAP1 [34] , though interaction with both TAP chains has also been claimed [35] . It is thus not clear whether the conformational effect of nucleotide binding by TAP1 is indeed a local effect or is transduced to TAP2 as well. Nucleotide binding by TAP1 may cause changes in the overall conformation of the transporter [14].
The remarkable properties of the nondestructive P loop mutation MUT III strongly support the view that the two TAP chains function asymmetrically in the transport cycle. The mutation does not affect nucleotide binding by either chain, and it is consistent with our previous discussion in that peptide binding is also not impaired. However, the mutation essentially disables the trans- porter when it is present only in TAP2, while, if anything, increasing its activity relative to the wild type when it is present only in TAP1. These data show that the TAPspecific residues at positions 2 and 3 of the Walker A domain are of functional importance since they cannot be replaced by serines, which are frequently found in other eukaryotic and prokaryotic ABC transporters. That a delicate interactive property of the transporter has been altered by MUT III seems to follow also from the fact that the severe phenotype of MUT III in TAP2 is largely reverted by the parallel presence of MUT III in TAP1. It will be of interest to find out whether this is a TAPspecific phenomenon or whether the sequence variations at these positions that are seen between different ABC transporter families are of general importance. Results from mutations in the Walker A domain of the GTPase p21 ras and the ATPase adenylate cyclase might speak in favor of the latter assumption [18] . Our current data on mutation III do not allow an interpretation of the potential effect of this mutation on the activity of TAP. Nevertheless, they clearly point at structural differences between the NBDs of TAP1 and TAP2, and these differences support our view that TAP1 and TAP2 serve different respectively. The postulated "nucleotide-off configuration" in the second half on the cycle is characterized by the nucleotide-free
In Figure 7 we present a working model of the TAP state of TAP1 (step 4). We assume that this proposed transient stage might be related to the nonpermissive TAP-MHC complexes of transport cycle as a platform for future work. The underly-TAP2/1 I and TAP2/1 II in that it could allow peptides to inspect all ing hypothesis is that nucleotide binding and hydrolysis initiates ATP hydrolysis, perhaps as a result of peptide binding. It is postulated that ATP hydrolysis at TAP1 initiates peptide transport and releases ADP from TAP2 and that this leads to Step 2, with nucleotide bound by of class I molecules from the loading complex. If multiple TAP1 and a transient "nucleotide-off" state for TAP2
class I molecules are associated with a single loading comassumed in other models of ABC transport [29] . The entry plex [5] , this "pause" in the transport cycle could provide of ATP into the catalytic site of TAP2 (step 3) and its an opportunity for the released peptide to sample different subsequent hydrolysis (step 4) completes peptide transclass I allelic products. After the recharging of TAP1 with port and initiates the recovery phase, entailing release of ATP, the transporter approaches the ground state, releases ADP from TAP1 and a second transient "nucleotide-off" successfully loaded class I molecules (step 5), and associates state for TAP1. We propose that this state corresponds with a free, unloaded class I molecule in anticipation of (although it is evidently not identical) to the nonpermisthe next transport cycle. It must be stressed that the model sive state of the loading complex, described in Figure 4 , urgently needs direct experimental evidence for the exisin which, in the absence of nucleotide binding by TAP1, tence of the ATP bound and hydrolytically active state of TAP2 that is represented by steps 3 and 4. peptide binding to class I molecules fails to induce release X-100 [Sigma]). Immunoprecipitations with anti-rat TAP2 (116/5) were It will be of interest to find out how the asymmetry in performed as described previously [41] . For the characterization of TAP nucleotide binding between TAP1 and TAP2 is detercomplexes, anti-rat TAP2 antiserum (116/5) was covalently coupled to mined. Our own data show that sequences of the transmemprotein A-sepharose (Amersham) with the help of dimethylpimelimidate brane domains do not influence the nucleotide binding of [42] . Digitonin lysates were incubated with matrix-coupled antibodies for 90 min at 4ЊC. Precipitates were washed five times with TBS con-TAP1 and TAP2 and suggest that intrinsic properties of the effectors modifying the conformation of TAP during the transport cycle. For the uptake of peptide, it is critically Transport and peptide crosslinking assay important that both TAP subunits are in a nucleotide
Both assays were performed as described before [9] .
bound state, whereas the undocking of loaded MHC class
Nucleotide binding assay
I molecules is mainly regulated by the nucleotide binding
The nucleotide binding assay was performed as described previously state of TAP1. Furthermore, our findings indicate that at [9] . Photolabeling of TAP with 8-azido-ATP[␥-32 P] was performed acresting state ATP is bound to the NBD of TAP1, while cording to Russ and coworkers [21] . Membranes of cells were prepared ADP is bound to the NBD of TAP2. This would be as described above and were resuspended in 250 mM sucrose, 50 mM KCl, 2 mM MgCl 2 , 2 mM EGTA and 10 mM Tris (pH 6. process. Supporting this view, we could demonstrate that on ice. Samples were diluted to 1 ml with lysis buffer containing 1% Triton X-100, and immunoprecipitation with anti-TAP2 antiserum was identical mutations in the NBD of TAP1 and TAP2 lead performed as described above. We separated immunoisolated material to a strikingly different transport activity. Thus, the two with SDS-PAGE, and we visualized reactive species by exposing the NBDs seem to serve distinct functions during the transdried gels to phosphorimager screens and by fluorography.
port cycle.
Flow cytometry
Flow cytometry was performed as described previously [9] .
Materials and methods
Cell lines and cell culture
Note added in proof
T2 is a human lymphoblastoid cell line that lacks both TAP genes and of T2 containing rat TAP1 a and rat TAP2 a , which have been described that mutation K607M in TAP1 and K509M in TAP2, which are different previously [37] , were cultured in IMDM (Gibco BRL) supplemented with from our mutations, have distinct effects on nucleotide binding and peptide 10% FCS (BIO Whittaker) and 1 mg/ml G418 (PAA, Cö lbe).
transport. From their results the authors suggest that nucleotide binding to TAP 1 is not a requirement for peptide binding to the TAP complex. Furthermore, in contrast to our view, they postulate that TAP2 constitutes the first
Cloning and expression of mutant TAP
ATP hydrolysis and that TAP1 is required to reset the transporter for another Mutagenesis of the Walker A site in rat TAP2 a and TAP1 a cDNA [38, cycle. 39] with the mutations I and II was performed as previously described [9] . We performed mutagenesis of the Walker A site in rat TAP2 a and Westfalen through the University of Cologne.
Supplementary material
Stable transfectants were maintained in IMDM supplemented with 10% FCS and 750 ng/ml puromycin. In addition, we also cultivated cell clones
